Wells Fargo & Company MN Buys 89,060 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Wells Fargo & Company MN boosted its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 618.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 103,465 shares of the company's stock after acquiring an additional 89,060 shares during the quarter. Wells Fargo & Company MN owned approximately 1.12% of Semler Scientific worth $5,587,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in SMLR. Principal Financial Group Inc. lifted its stake in shares of Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock valued at $6,074,000 after purchasing an additional 97,144 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Semler Scientific by 10.5% in the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company's stock worth $3,202,000 after purchasing an additional 12,964 shares during the last quarter. IFP Advisors Inc bought a new stake in Semler Scientific during the fourth quarter worth approximately $54,000. Jane Street Group LLC grew its holdings in Semler Scientific by 72.3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company's stock valued at $400,000 after purchasing an additional 7,126 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Semler Scientific by 11.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company's stock worth $2,626,000 after buying an additional 4,802 shares during the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Semler Scientific Price Performance

SMLR stock traded up $0.50 on Thursday, reaching $34.78. 34,644 shares of the company were exchanged, compared to its average volume of 400,990. The firm has a market capitalization of $333.82 million, a PE ratio of 7.08 and a beta of 1.29. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The stock's fifty day moving average price is $37.69 and its 200 day moving average price is $45.82.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $3.21. The business had revenue of $12.41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital boosted their price objective on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.